Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment

SIMPLE SUMMARY: Triple-negative breast cancer accounts for 15–20% of breast tumors. It is a very aggressive and heterogeneous disease characterized by the absence of druggable molecular targets. In that context, understanding the role of non-coding RNAs and their implication in tumorigenesis could r...

Descripción completa

Detalles Bibliográficos
Autores principales: Palcau, Alina Catalina, Brandi, Renata, Mehterov, Nikolay Hristov, Botti, Claudio, Blandino, Giovanni, Pulito, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453179/
https://www.ncbi.nlm.nih.gov/pubmed/37627209
http://dx.doi.org/10.3390/cancers15164181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453179/
https://www.ncbi.nlm.nih.gov/pubmed/37627209
http://dx.doi.org/10.3390/cancers15164181

Ejemplares similares